Vani Sundaraiyer, PhD, MS

Ms
Inventiv Health Clinical LLC

Disclosure: Pfizer (Individual(s) Involved: Self): Independent Contractor

Presentation(s):

• 3 - Phase 3 Pivotal Evaluation of 20-valent Pneumococcal Conjugate Vaccine (PCV20) Safety, Tolerability, and Immunologic Noninferiority in Participants 18 Years and Older

  Oral Abstract